19-Substituted benzoquinone ansamycin Hsp90 inhibitors: Effects on Hsp90 co-chaperones and Hsp90-Hsf1 complexes in cellular systems

被引：0
|
作者：
Drechsel, Derek A. [1 ]
Chang, Chuan-Hsin [1 ]
Kitson, Russell [2 ]
Siegel, David [1 ]
Moody, Christopher J. [2 ]
Ross, David [1 ]
机构：
[1] Univ Colorado Anschutz Med Campus, Aurora, CO USA
[2] Univ Nottingham, Nottingham NG7 2RD, England
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-1791
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1791
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Better HSP90 inhibitors
    Harrison Charlotte
    Nature Reviews Drug Discovery, 2013, 12 (5) : 346 - 346
  • [22] Inhibitors of HSP90 in melanoma
    Mielczarek-Lewandowska, Aleksandra
    Hartman, Mariusz L.
    Czyz, Malgorzata
    APOPTOSIS, 2020, 25 (1-2) : 12 - 28
  • [23] HSP90 and its inhibitors
    Hao, Huifang
    Naomoto, Yoshio
    Bao, Xiaohong
    Watanabe, Nobuyuki
    Sakurama, Kazufumi
    Noma, Kazuhiro
    Motoki, Takayuki
    Tomono, Yasuko
    Fukazawa, Takuya
    Shirakawa, Yasuhiro
    Yamatsuji, Tomoki
    Matsuoka, Junji
    Takaoka, Munenori
    ONCOLOGY REPORTS, 2010, 23 (06) : 1483 - 1492
  • [24] Inhibitors of HSP90 and other chaperones for the treatment of cancer
    Dymock, BW
    Drysdale, MJ
    McDonald, E
    Workman, P
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (06) : 837 - 847
  • [25] Interaction of cepharanthine with immobilized heat shock protein 90α (Hsp90α) and screening of Hsp90α inhibitors
    Haginaka, Jun
    Kitabatake, Tomoko
    Hirose, Iyo
    Matsunaga, Hisami
    Moaddel, Ruin
    ANALYTICAL BIOCHEMISTRY, 2013, 434 (01) : 202 - 206
  • [26] Distinct Roles of Molecular Chaperones HSP90α and HSP90β in the Biogenesis of KCNQ4 Channels
    Gao, Yanhong
    Yechikov, Sergey
    Vazquez, Ana E.
    Chen, Dongyang
    Nie, Liping
    PLOS ONE, 2013, 8 (02):
  • [27] Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease
    Blair, Laura J.
    Sabbagh, Jonathan J.
    Dickey, Chad A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (10) : 1219 - 1232
  • [28] Comparison of the cellular and biochemical properties of ansamycin and non-ansamycin based Hsp90 inhibitors
    Fritz, C.
    Tillotson, B.
    Ge, J.
    Normant, E.
    Depew, K.
    Basuki, J.
    Hafeez, N.
    Patterson, J.
    Porter, J. R.
    Palombella, V.
    EJC SUPPLEMENTS, 2008, 6 (12): : 48 - 48
  • [29] A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
    Kamal, A
    Thao, L
    Sensintaffar, J
    Zhang, L
    Boehm, MF
    Fritz, LC
    Burrows, FJ
    NATURE, 2003, 425 (6956) : 407 - 410
  • [30] Targeting the Hsp90 Chaperone: Synthesis of Novel Resorcylic Acid Macrolactone Inhibitors of Hsp90
    Day, James E. H.
    Sharp, Swee Y.
    Rowlands, Martin G.
    Aherne, Wynne
    Workman, Paul
    Moody, Christopher J.
    CHEMISTRY-A EUROPEAN JOURNAL, 2010, 16 (09) : 2758 - 2763
12345